R1	Has_temporal Arg1:T2 Arg2:T3	
*	OR T6 T7
R2	Has_value Arg1:T4 Arg2:T6	
*	OR T10 T11 T12 T13 T14 T15 T16
R3	Subsumes Arg1:T9 Arg2:T10	
R4	Has_value Arg1:T19 Arg2:T20	
R5	Subsumes Arg1:T18 Arg2:T19	
R6	Has_negation Arg1:T22 Arg2:T21	
*	OR T24 T25
R7	Has_value Arg1:T23 Arg2:T24	
R8	Has_value Arg1:T28 Arg2:T29	
R9	Has_value Arg1:T30 Arg2:T31	
T1	Informed_consent 0 72	Capacity to provide informed consent before any trial-related activities
T2	Condition 86 90	T2DM
T3	Temporal 92 100	=3months
T4	Measurement 103 108	HbA1c
T5	Measurement 0 110	Capacity to provide informed consent before any trial-related activities
T6	Value 109 113	= 9%
T7	Value 138 143	= 10%
T9	Procedure 203 227	glucose lowering therapy
T10	Drug 278 287	metformin
T11	Drug 289 302	sulphonylurea
T12	Drug 304 321	DPP-IV inhibitor,
T13	Drug 322 335	GLP-1 therapy
T14	Drug 342 347	SGLT2
T15	Observation 352 356	diet
T16	Observation 361 369	exercise
T18	Condition 402 410	diabetes
T19	Measurement 417 422	HbA1c
T20	Value 423 429	> 6.5%
T21	Negation 432 435	not
T22	Procedure 457 481	glucose lowering therapy
T23	Measurement 513 528	Body mass index
T24	Value 529 538	> 30Kg/m2
T25	Value 542 554	> 27.5 Kg/m2
T27	Condition 584 588	T2DM
T28	Person 600 603	age
T29	Value 589 595;607 622	before 60 years of age
T30	Person 624 627	Age
T31	Value 628 646	=18 and = 65 years
